CD86 and neoplasm: In a dual tumor model, low‐dose total body irradiation (0.1 Gy) combined with hypofractionated irradiation (8 Gy × 3) of BALB/C‐derived mammary carcinoma 4T1 cells increased the number of CD86+ DC cells in the secondary tumor.52